JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorn II, G. W.
Right arrow Articles by D'Angelo, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorn II, G. W.
Right arrow Articles by D'Angelo, D. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 19, Issue of May 9, 1997 pp. 12399-12405
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors
ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS

(Received for publication, November 26, 1996, and in revised form, February 27, 1997)

Gerald W. Dorn II , Michael G. Davis and Drew D. D'Angelo

From the University of Cincinnati and the Cincinnati Veterans Administration Medical Center, Cincinnati, Ohio 45267-0542

The two most extensively characterized thromboxane/prostaglandin endoperoxide (TP) receptors, from human platelets and rat vascular smooth muscle, exhibit thromboxane agonist [15-(1alpha ,2beta (5Z),3alpha -(1E,3S),4alpha )]-7-[3-hydroxy-4-(p-iodophenoxy)-1-butenyl-7-oxabicycloheptenoic acid (I-BOP) binding affinities that differ by an order of magnitude, rat TP having the higher affinity. We utilized this difference in I-BOP affinity to identify structural determinants of TP receptor heterogeneity. No significant difference was found in the rank order of affinities for a series of thromboxane receptor ligands to bind to cloned human TPalpha versus rat TP, indicating that these represent species homologs, not distinct TP subtypes. Structural determinants for observed differences in I-BOP binding Kd were localized by creating chimeric human/rat TP followed by mutational substitution of specific critical amino acids. Initially, seven chimeric receptors with splice sites in transmembranes 1, 2, 4, or 7 were constructed and expressed in HEK293 cells for analysis of ligand binding properties. Substitution of any part except the carboxyl tail of the human TP into the rat TP resulted in a receptor with I-BOP binding affinity intermediate between the two. Analysis of chimeras in which only the extracellular amino terminus and a portion of transmembrane 1 were switched localized the determinant of high affinity binding to the region between amino acids 3 and 40. Using this chimera, amino acids in the human portion (extracellular amino terminus and part of transmembrane 1) were replaced with analogous amino acids from rat TP to regain high affinity I-BOP binding. Only when amino acid Val37 and either Val36 or Ala40 were reverted to their respective rat TP counterparts (Ala36, Leu37, and Gly40, respectively) was high affinity I-BOP binding recovered. The mechanism for the increased I-BOP affinity may be the lengthening of the amino acid side chain at position 37, thus extending this group further into the putative I-BOP binding pocket, with compensatory shortening of side chains in spatially adjacent amino acids.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton
Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein
J. Biol. Chem., September 15, 2006; 281(37): 26951 - 26965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Zhang, C. DiLizio, D. Kim, E. M. Smyth, and D. R. Manning
The G12 Family of G Proteins as a Reporter of Thromboxane A2 Receptor Activity
Mol. Pharmacol., April 1, 2006; 69(4): 1433 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Qiao, D. Reynaud, P. Demin, P. V. Halushka, and C. R. Pace-Asciak
The Thromboxane Receptor Antagonist PBT-3, a Hepoxilin Stable Analog, Selectively Antagonizes the TP{alpha} Isoform in Transfected COS-7 Cells
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1142 - 1147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Turek, T. Halmos, N. L. Sullivan, K. Antonakis, and G. C. Le Breton
Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein
J. Biol. Chem., May 3, 2002; 277(19): 16791 - 16797.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Narumiya, Y. Sugimoto, and F. Ushikubi
Prostanoid Receptors: Structures, Properties, and Functions
Physiol Rev, October 1, 1999; 79(4): 1193 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Neuschäfer-Rube, M. Oppermann, U. Möller, U. Böer, and G. P. Püschel
Agonist-Induced Phosphorylation by G Protein-Coupled Receptor Kinases of the EP4 Receptor Carboxyl-Terminal Domain in an EP3/EP4 Prostaglandin E2 Receptor Hybrid
Mol. Pharmacol., August 1, 1999; 56(2): 419 - 428.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.